Search results (245)
« Back to News & Events
OxCODE scientists to explore RNA ‘fingerprints’ in the blood for early cancer detection
25 Sep, 2026
Building on an OxCODE Funding Scheme award, funding from Cancer Research UK will further the development of a new blood test that uses previously overlooked RNA modifications to identify cancer earlier and more accurately.
Blood tests could identify early signs of cancer years before diagnosis
22 Sep, 2026
A study of blood samples collected up to nine years before a cancer diagnosis found changes in the DNA that captured the body’s response to early traces of cancer development.
OxCODE symposium - Monday 7th December - Registration open!
11 Sep, 2026
On Monday 7th December 2026, join us for the OxCODE symposium 2026 to hear about the latest research in early cancer detection and prevention from Oxford and elsewhere.
Fallopian tube immune cells could offer new route to prevent and treat ovarian cancer
11 Sep, 2026
Research led by Professor Ahmed Ahmed and Dr Nancy Zaarour has identified a population of immune cells in the fallopian tubes that can recognise ovarian cancer cells, raising the possibility of harnessing the body's early immune defences to develop new ways to prevent or treat the disease.
Study of almost one million adults links very hot drinks to threefold increase in oesophageal cancer risk
10 Sep, 2026
Drinking tea and coffee at a very hot temperature, rather than warm, is linked to a threefold increase in the risk of oesophageal squamous cell carcinoma in large UK cohorts
Professor Bethan Psaila wins ISEH Janet Rowley Award
4 Sep, 2026
Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.
Funding to develop new drugs to prevent a type of inherited bowel cancer
28 Aug, 2026
Professor Simon Leedham and Professor Christian Siebold receive a Cancer Research UK Biology to Prevention award to enable drug discovery for cancer prevention in people with inherited polyposis syndromes.
Could GLP-1 drugs prevent blood cancers and other diseases of ageing?
27 Aug, 2026
A new international research programme led by OxCODE Associate Director Professor Philip Awadalla with Professor Stephanie Xie (Toronto) will investigate whether GLP-1 receptor agonists ‒ widely used to treat diabetes and obesity ‒ could be repurposed to prevent the progression of clonal haematopoiesis and its associated diseases.
New robotic technology to speed up lung cancer diagnosis
20 Aug, 2026
A new robotic-assisted system that supports early and accurate lung cancer diagnosis, while reducing the need for patients to travel long distances, has been unveiled at Oxford University Hospitals NHS Foundation Trust (OUH).
Oxford Sparks video on preventive cancer vaccines
6 Aug, 2026
In this new video from Oxford Sparks, Professor David Church describes his research to develop vaccines to prevent cancer.
Study shows AI can be safely deployed in NHS prostate cancer diagnosis
20 Jul, 2026
Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.
OxCODE funding scheme awards 2026
20 Jul, 2026
Congratulations to Ray DiNardi, Christiana Kartsonaki, Giuseppina Pisignano, Niyas Salam, Jie Yang and their collaborators who have been awarded funding in the seventh round of the OxCODE Funding Scheme.
OxCODE travel awards 2026
10 Jul, 2026
Congratulations Kiana Collins, Arianna De Chiara and Michalis Pistos who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.
Blood test could help doctors diagnose cancers faster, Oxford study suggests
9 Jul, 2026
Analysis of 2-year follow-up data from the NHS SYMPLIFY trial found a multi-cancer blood test could help speed up cancer diagnosis for some patients with symptoms, potentially reducing delays and directing people to the right investigations sooner.
Oxford researchers hunt for hidden protein clues to prevent prostate cancer
10 Jun, 2026
A major new research programme, led by Professor Ruth Travis and Dr Karl Smith-Byrne and funded by Cancer Research UK, aims to uncover the biological causes of prostate cancer and identify ways to prevent the disease.
First trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford
9 Jun, 2026
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
OxCODE Associate Director Professor Ellie Barnes named BRC Oxford Deputy Director
5 Jun, 2026
Professor Ellie Barnes has been appointed as Deputy Director of the NIHR Biomedical Research Centre: Oxford.
World’s largest study of women’s health marks 30 years of pioneering research
8 May, 2026
The Million Women Study has generated landmark findings on HRT and cancer risk, as well as other aspects of women's health
Funding for research to investigate how certain cancers turn aggressive
28 Apr, 2026
Dr Srinivasa Rao and Dr Beatriz Gamez Molina receive a Cancer Research UK Early Detection and Diagnosis Primer award to improve early detection and prevention of progression in prostate cancer and multiple myeloma.
New Oxford-led study set to evaluate multi-cancer tests in GP practices for earlier diagnosis
14 Apr, 2026
Clinical Associate Professor Brian Nicholson has received £3.6 million to explore whether multi-cancer tests can help GPs identify cancer earlier in people with non-specific symptoms.